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Historical background
The idea that a distinct population of T lymphocytes with suppressive properties exists was first proposed by Gershon and Kondo [1, 2] in the early 1970s. Few aspects of immunology have such a checkered history. During the late 1970s and early 1980s, several groups generated suppressor T-cell hybridomas from mice [3, 4] . Data obtained from these cell lines contributed to the construction of an elaborate cascade of suppressor T cells, referred to as TS1, TS2, and TS3. These hybridomas were claimed to secrete antigen-binding suppressor factors, which carried the major histocompatibility complex (MHC) class II-encoded determinant I-J. The advent of modern molecular genetics exploded much of this literature and relegated suppressor cells, as then defined, to mythology [5, 6] . Many of these hybridomas had not rearranged their T-cell receptor genes, and the MCH class II region did not contain any genes in the supposed I-J region [7] . It was some years before the shadow of this episode of immunologic history retreated. However, through this period, one phenomenon remained robust: the adoptive transfer of acquired transplantation tolerance by T cells. The first attempt to rescue suppressor T cells from the shadows was based on insights into T helper cell polarization. It was argued that T cells polarized toward a Th2 phenotype might maintain transplantation tolerance by regulating proinflammatory Th1 antidonor alloreactive T cells. Although some observations in experimental transplant models lent support to this hypothesis, a comparable volume of data appeared to contradict it. Perhaps most telling were the findings that polarized Th2 T cells could effect transplant rejection [8] [9] [10] [11] [12] [13] . Two important observations have taken this field a substantial step forward. The first was the discovery of a naturally occurring population of T cells in mice that coexpressed CD4 and CD25 receptors [14, 15] . These cells appear to play a key role in the prevention of autoimmunity. A second important set of observations highlighted the immune regulatory potential of two cytokines, interleukin-10 and tumor growth factor ␤ [16-22].
Putting a large body of data together, it appears that a spectrum of T-cell populations with suppressive properties, either induced or naturally occurring, have been implicated in the prevention of autoimmune diseases, allotransplantation tolerance, and attenuation of antitumor immune responses. These cells have been reborn under the name regulatory T cells, partly to dissociate them from their shady predecessors, the suppressor T cells.
Regulatory T-cell populations Naturally occurring regulatory T cells
In 1995, Shimon Sakaguchi [23] reported the key finding that the propensity of mice thymectomized at day 3 of age to develop a variety of autoimmune diseases was correlated with the lack of a minor population of splenic T cells coexpressing CD4 and CD25 receptors, and adoptive transfer of this T-cell population from normal mice into thymectomized animals protected from autoimmunity [14, 15] . During the ensuing 7 years, a large body of literature has accumulated concerning this cell population. A series of key findings have been reported. (Table 1) .
Induced regulatory T cells
In addition to these spontaneously arising regulatory T cells, it appears to be possible to steer an uncommitted T cell toward regulatory function by repetitive stimulation with immature dendritic cells or in the presence of regulatory cytokines such as interleukin-10 and tumor growth factor ␤. Cells of the CD4 + lineage, the CD8 + lineage, and CD3
+ CD4 -CD8 -double-negative cells of this type have been reported. All types of induced regulatory T cells that have been described are summarized in Table  2 . The limitation of most of these studies is that they have largely been based on in vitro manipulations. Limited data exist to suggest that the same kind of induced regulatory T cells exist or are generated in the course of tolerance induction protocols in vivo. Buer et al. [40] , using double transgenic mice expressing both a class IIrestricted TCR specific for influenza hemagglutinin and the hemagglutinin itself under the control of the Ig promoter, have shown that prolonged exposure to antigen stimulation in vivo can result in the generation of a population of T cells with regulatory properties. These cells showed signs of activation in vivo but were anergic in terms of proliferation when restimulated in vitro; the anergic state could not be reversed by addition of exogenous interleukin-2. The hypoproliferative hemagglutinin antigen (HA)-specific cells, in contrast to their naive precursors, failed to induce diabetes when injected into recipients that expressed HA under the control of the insulin promoter. However, they were able to produce higher levels of interleukin-10 than their naive counterparts, suggesting that they may have regulated immune response through the release of interleukin-10. 
Regulatory T cells in transplantation tolerance
As mentioned, some of the most convincing evidence for dedicated regulatory T cells was derived from experimental models of transplantation tolerance. In many such models, tolerance could be transferred to a naive animal, almost invariably by CD4 + T cells, such that the transferred T cells would protect a challenge graft bearing the antigens to which the T-cell donor was tolerant. Two key points concerning the adoptive transfer of transplantation tolerance have emerged. The first concerns their specificity and the second their efficacy.
Regulatory T cells that maintain transplantation tolerance have indirect allospecificity
Several lines of evidence indicate that the T cells that can transfer transplantation tolerance have indirect specificity for donor antigens. Perhaps the first indication that this was the case came from antigen pretreatment models before mouse heart transplantation. Pretreatment with a single donor class I alloantigen could substantially prolong the survival of heart grafts bearing class I and class II mismatches. Most importantly, the effect of the class I antigen pretreatment was substantially augmented by simultaneous administration of nondepleting anti-CD4 monoclonal antibodies [46] [47] [48] . These data strongly suggested that CD4 + T cells recognizing the class I antigen indirectly were instrumental in the development of subsequent transplant tolerance. Similar conclusions can be drawn from experiments in which peptides corresponding to sequences of donor class I antigens were injected intrathymically in rats, leading to acceptance of allografts coexpressing class I and class II alloantigens. It is likely, although not proven, that these intrathymic peptides were presented by host MHC class II molecules inducing CD4 + regulatory T cells with indirect antidonor specificity. The capacity of killed or sonicated allogeneic cells to induce oral tolerance of murine corneal allografts further suggested regulation by indirect pathway T cells [49] . Two additional pieces of evidence lead to the same conclusion. When CD4 + CD45 RB low T cells from CBA mice tolerant of B10 cardiac allografts were tested in vitro, their suppressive properties could be revealed only when (CBA × B10) F1 APC were used, strongly suggesting that indirect presentation of B10 antigens by H2k class II molecules was responsible for activating the regulatory T cells [21] . Finally, in another mouse cardiac allograft model, Yamada et al. [50] made the surprising observation that C3H hearts transplanted into B6 mice under the cover of double costimulatory blockade (CTLA4 Ig + anti-CD40 ligand monoclonal antibody) survived indefinitely. In striking contrast, when the same hearts were transplanted into mice that were incapable of indirect allorecognition, MHC class II knockout mice injected with CD4 + T cells from wild-type animals, all the grafts were rejected once the levels of costimulatory blockade declined. These data supplement those indicating that regulatory T cells have indirect allospecificity and suggest that transplantation tolerance cannot be achieved in the absence of the indirect pathway. + T cells can suppress the mixed lymphocyte reaction increased with the degree of the HLA-DR matching (Game and Lechler, unpublished data). This observation supports the authors' initial hypothesis that CD4 + CD25 + T cells are self-MHC restricted and most efficiently regulate indirect, rather than direct, alloresponses presumably specific for a variety of self-peptides. Furthermore, the authors have been able to generate T-cell lines with indirect allospecificity from human peripheral blood CD4 + CD25 + T cells. These cell lines retained their suppressive properties and were able to inhibit direct and indirect alloresponses (Jiang and Lechler, unpublished data).
Limitations of T-cell regulation in achieving transplantation tolerance
Although the adoptive transfer of transplantation tolerance is a robust and reproducible phenomenon and provides some of the best evidence in support of regulatory T cells, the power of this regulation has clear limitations. A critical examination of the transplantation tolerance literature reveals that transferable regulation is usually seen in the context of minor histocompatibility antigen, or isolated MHC class I, differences. When tolerance has been transferred between fully MHC-incompatible strains of mice or rats, it was usually necessary either to compromise the recipients' immune systems by a sublethal dose of irradiation or to use a T-cell-deficient animal [51,52••].
These data suggest that the regulatory mechanisms that arise in the context of transplantation tolerance are incapable of controlling a high-frequency alloresponse such as that provoked by the direct pathway of MHC allorecognition. Taking into account the observations outlined concerning the apparent indirect allospecificity of regulatory T cells in this context, one interpretation of these findings is that regulation does and can control the indirect pathway of antidonor alloimmunity, but not the direct pathway.
Several groups have highlighted the need for a wave of T-cell deletion to establish transplantation tolerance [53••,54,55] . Indeed, when mice transgenic for the survival gene, Bcl XL , were used as transplantation recipients, conventional tolerance protocols were unsuccessful.
In addition, they demonstrated that rapamycin, a drug that allows peripheral T-cell deletion caused by activation-induced cell death (AICD), is tolerance-permissive, whereas calcineurin inhibitors, which tend to inhibit AICD, are not. An alternative strategy to achieve deletion of alloreactive T cells is to induce hematopoietic stem cell chimerism. This strategy, which was first investigated by Medawar and was championed more recently by Sachs et al. and Sykes et al. [56•, [57] [58] [59] , may play a key role in the induction of antidonor T-cell deletion in the thymus.
An emerging view is that deletion and regulation are highly complementary and may well both be necessary if long-term transplantation tolerance is to be achieved.
Conclusions
Although much progress has been made during the past few years, many key questions concerning regulatory T cells remain to be addressed before their properties can be exploited in the arena of transplantation. Key issues include the relation between the various populations of regulatory T cells that have been described. One attractive concept is that the regulatory T cells of the innate immune system, natural killer T cells, foster the development of regulatory T cells of the adaptive immune response, such as CD4 + CD25 + T cells. The specificity and mechanism of action of these spontaneously arising regulatory T cells is another crucial issue, particularly if these cells are to be induced deliberately in vivo. Given the power of modern systems biology, there can be little doubt that the molecular basis of T-cell regulation will be elucidated in the near future, which may open up new and exciting possibilities in the field of immunotherapy. 
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